Actor
Mimix Biotherapeutics AG
Established in 2019, the company leverages Sound Induced Morphogenesis (SIM), a proprietary technology that uses sound in conjunction with cells, stem cells, spheroids, organoids & bioactives, to create tissue relevant architectures (bio-patterns).
Specialties
Primary Therapeutic Areas
0. COVID-19
1.5 Medical Technology
1.61 Orthopaedic & Rehabilitation
1.63 Regenerative therapy
1.66 3D-Printing
4.0 Consulting & Services
4.08 Product Development
5.0 Medical Device & Parts
5.00 Biomaterials
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
Visit website
Domains
COVID-Areas, Dermatology, Endocrine & Metabolic, Infectious Diseases, Respiratory
Main sector
Medtech
Contact
Rue d'Arrberg 46
2503 Bienne / BE